Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)

South Korea · Delayed Price · Currency is KRW

4,140.00

+120.00 (2.99%)

At close: Jul 31, 2026

Sinsin Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	118,649	113,778	106,388	102,586	91,926	74,008
Revenue Growth	10.90%	6.95%	3.71%	11.60%	24.21%	10.25%
Gross Profit	45,680	43,009	36,110	33,312	30,220	21,689
Operating Income	12,695	10,790	6,890	6,004	5,426	-1,343
Net Income	11,151	9,292	4,888	4,680	4,415	-1,476
Earnings Per Share	735.72	612.51	322.00	308.49	291.00	-97.29
EPS Growth	102.39%	90.22%	4.38%	6.01%	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	4,373	3,876	539.85	346.46	2,240	799.33
Total Debt	40,846	43,695	45,606	44,505	43,481	46,236
Net Cash (Debt)	-36,473	-39,818	-45,066	-44,158	-41,241	-45,437
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2406.42	-2624.72	-2968.47	-2910.81	-2718.51	-2995.06

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	12,157	8,584	5,943	3,930	5,461	23.18
Capital Expenditures	-2,046	-1,612	-1,505	-5,011	-907.13	-2,682
Free Cash Flow	10,111	6,971	4,439	-1,081	4,553	-2,659
Free Cash Flow Growth	121.53%	57.05%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	38.50%	37.80%	33.94%	32.47%	32.87%	29.31%
Operating Margin	10.70%	9.48%	6.48%	5.85%	5.90%	-1.81%
Pretax Margin	10.18%	8.62%	4.83%	3.89%	4.40%	-2.36%
Profit Margin	9.40%	8.17%	4.59%	4.56%	4.80%	-1.99%
FCF Margin	8.52%	6.13%	4.17%	-1.05%	4.95%	-3.59%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	60.000	-	-	-	-	-
Dividend Per Share Growth	33.33%	-	-	-	-	-
Dividend Yield	1.45%	-	-	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	5.63	9.57	16.85	20.23	19.18	-
P/FCF Ratio	6.21	12.75	18.56	-	18.59	-
PS Ratio	0.53	0.78	0.77	0.92	0.92	1.32